February 2026
1. APPLEBAUM AJ, Manschot C, Kuhn E, Laber E, et al
   Assessing the utility of the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors.
   Cancer. 2026;132:e70285.
   

   >> Share

   
   December 2025
2. SICURANZA A, Pacelli P, Santoni A, Raspadori D, et al
   Reply to "Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!".
   Cancer. 2025;131:e70214.
   

   >> Share

   
   
3. OZDEMIR ZN, Eskazan AE
   Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!
   Cancer. 2025;131:e70215.
   

   >> Share

   
   
4. WANNAPHUT C, Chumnumsiriwath P, Ciurea SO, Kongtim P, et al
   Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.
   Cancer. 2025;131:e70199.
   

   >> Share

   
   November 2025
5. QIAN CS, Wang ZH, Li Z, Yao Z, et al
   A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leuk
   Cancer. 2025;131:e70168.
   

   >> Share

   
   October 2025
6. SICURANZA A, Pacelli P, Santoni A, Abruzzese E, et al
   Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study.
   Cancer. 2025;131:e70122.
   

   >> Share

   
   May 2025
7. LUDWIG H, Bernhard S, Ikeda T, Freytes CO, et al
   Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review.
   Cancer. 2025;131:e35896.
   

   >> Share

   
   
8. ZHAO X, Liu Z
   Concerns regarding stem cell mobilization in liposomal mitoxantrone therapy for relapsed/refractory T-cell/natural killer-cell lymphomas.
   Cancer. 2025;131:e35848.
   

   >> Share

   
   
9. GAO Y, Huang HQ
   Reply to "Concerns regarding stem cell mobilization in liposomal mitoxantrone therapy for relapsed/refractory T-cell/natural killer-cell lymphomas".
   Cancer. 2025;131:e35847.
   

   >> Share

   
   April 2025
10. PENG X, Jing X, Li T, Cheng J, et al
    Serum of interleukin-6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation.
    Cancer. 2025;131:e35835.
    

    >> Share

    
    May 2024
11. SENAPATI J, Kantarjian HM, Bazinet A, Reville P, et al
    Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
    Cancer. 2024 May 29. doi: 10.1002/cncr.35388.
    

    >> Share

    
    
12. RICHARDSON NH, Taza F, Abonour R, Althouse SK, et al
    High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience.
    Cancer. 2024 May 20. doi: 10.1002/cncr.35375.
    

    >> Share

    
    
13. BAZARBACHI AH, Labopin M, Raiola AM, Blaise D, et al
    Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Tran
    Cancer. 2024 May 17. doi: 10.1002/cncr.35365.
    

    >> Share

    
    April 2024
14. GIRI S, Harmon C, Landier W, Chen Y, et al
    Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma.
    Cancer. 2024 Apr 5. doi: 10.1002/cncr.35298.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share